V-domain immunoglobulin suppressor of T cell activation (VISTA) inhibits T-cell effector functions and helps tumor immune evasion, making it an important biomarker and therapeutic target in cancer immunotherapy.
To facilitate VISTA-targeted strategy development and enable the accurate detection of tumor VISTA expression, a novel small-molecule probe [
